MSX opens pre-IPO subscriptions for Neuralink and Anduril

RWA platform MSX announced the launch of subscriptions for Neuralink and Anduril as part of its third pre-IPO investment offering. Neuralink, based on a $42 billion valuation, is being offered in a total size of $3 million with a subscription price of 219 USDT, while Anduril, based on a $115 billion valuation, is being offered in a total size of $3 million at 130 USDT. The subscription period runs from Aug. 31 to Sept. 6, and users can participate within allocation limits tied to assets held on MSX.